Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

Anemia of Chronic Disease

2005 • 3,522 citations

EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS

1986 • 1,412 citations

Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor Cells

1990 • 837 citations

Decreased Erythropoietin Response in Patients with the Anemia of Cancer

1990 • 680 citations

High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis

1977 • 622 citations

Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]

1992 • 612 citations

Effect of inflammatory cytokines on hypoxia-induced erythropoietin production

1992 • 518 citations

Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.

1993 • 517 citations

Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization

1988 • 464 citations

Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney.

1988 • 448 citations

The renal pathology in clinical trials of Cis-platinum (II) diamminedichloride

1977 • 345 citations

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

1990 • 313 citations

Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in man

1978 • 306 citations

Recombinant Human Erythropoietin Treatment in Pre-Dialysis Patients

1989 • 240 citations

Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy

1993 • 207 citations

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.

1994 • 205 citations

Exposure and accumulation of cadmium in populations from Japan, the United States, and Sweden

1979 • 204 citations

Assessment of exposure to lead and cadmium through biological monitoring: Results of a UNEP/WHO global study

1983 • 200 citations

Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.

1987 • 190 citations

Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

1976 • 179 citations

The kidney and erythropoiesis

1968 • 176 citations

Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice

1989 • 171 citations

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

1972 • 168 citations

Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin [see comments]

1991 • 158 citations

Enhanced drug metabolism in cigarette smokers.

1976 • 125 citations

Renal magnesium wasting associated with amphotericin B therapy

1984 • 121 citations

Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.

1991 • 119 citations

Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

1971 • 106 citations

Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo

1990 • 96 citations

The long-term effect of cisplatin on renal function

1986 • 89 citations

Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

1992 • 85 citations

Cisplatin-Induced Hemolysis

1980 • 83 citations

Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats.

1982 • 76 citations

Characterization of the Anaemia of Chronic Renal Failure and the Mode of its Correction by a Preparation of Human Erythropoietin (r-HuEPO). An Investigation of the Pharmacokinetics of Intravenous Erythropoietin and its Effects on Erythrokinetics

1989 • 71 citations

Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen

1989 • 70 citations

Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu.

1979 • 68 citations

Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.

1989 • 68 citations

Amphotericin B Blunts Erythropoietin Response to Anemia

1990 • 65 citations

Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia

1994 • 64 citations

Circadian time dependence of cisplatin urinary kinetics

1982 • 62 citations

Effect of recombinant human erythropoietin on anticancer drug‐induced anaemia

1990 • 49 citations

Effect of inflammatory cytokines on hypoxia-induced erythropoietin production

1992 • 48 citations

Erythropoietin Deficiency in Acute Renal Failure

1990 • 46 citations

Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer

1996 • 43 citations

Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization

1988 • 36 citations

Exposure and Accumulation of Cadmium in Populations from Japan, the United States, and Sweden

1979 • 35 citations

Hepatitis-related hepatic erythropoietin production

1990 • 32 citations

Recombinant Human Erythropoietin in Patients with Ovarian Carcinoma and Anaemia Secondary to Cisplatin and Carboplatin Chemotherapy: Preliminary Results

1992 • 32 citations

UNEXPECTED MOBILISATION OF LEAD DURING CISPLATIN CHEMOTHERAPY

1986 • 31 citations

Effects of cisplatin on different haemopoietic progenitor cells in mice

1982 • 30 citations

Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy

1991 • 28 citations

Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals

1984 • 26 citations

Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment

1990 • 26 citations

Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice

1989 • 16 citations

Pharmacokinetics of therapeutic doses of isotopically labeled platinum antitumor agents in the mouse and rat.

1983 • 8 citations

Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia

1994 • 6 citations

Renal Magnesium Wasting Associated with Amphotericin B Therapy

1985 • 3 citations